로딩 중…
지수 로딩 중…
Geron Corporation
GERN· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$1.28-0.78%
2026-08-03
Financials
Valuation Metrics
Geron Corporation's Market Cap is $821M. At end of 2025 it was $881M. Ranked #2582 of 3,111 in US market (top 83%), #1080 of 1,445 on NASDAQ (top 75%), #202 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 75%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $821M | US#2,582/3,111 Sec#202/269 |
| Revenue | $196M | US#2,694/3,111 Sec#115/269 |
| Net Income | $-70M | US—/3,111 Sec—/269 |
| Total Assets | $534M | US#2,727/3,111 Sec#149/269 |
| Net Assets | $229M | US#2,694/3,111 Sec#188/269 |
| Value | ||
| P/B | 3.58x | US#1,890/3,111 Sec#114/269 |
| P/S | 4.19x | US#2,146/3,111 Sec#67/269 |
| FCF Yield | -15.38% | US—/3,111 Sec—/269 |
| Profitability | ||
| ROE | -30.37% | US#2,621/3,111 Sec#127/269 |
| ROA | -13.03% | US#2,700/3,111 Sec#111/269 |
| Op. Margin | -19.05% | US#2,698/3,111 Sec#106/269 |
| Revenue Growth | 30.89% | US#491/3,111 Sec#69/269 |
| Financial Health | ||
| Debt Ratio | 133.13% | US#1,369/3,111 Sec#181/269 |
| Total Debt | $252M | US#2,133/3,111 Sec#84/269 |
| FCF | $-126M | US#2,644/3,111 Sec#170/269 |
| Cash | $71M | US#2,420/3,111 Sec#206/269 |
| Current Ratio | 6.78x | US#349/3,111 Sec#116/269 |
| Performance | ||
| 1Y Return | 9.40% | US#1,654/3,111 Sec#176/269 |
| 1M Return | -5.88% | US#1,317/3,111 Sec#83/269 |
| From 52W High | -36.32% | US#2,330/3,111 Sec#180/269 |
| 1Y MDD | -43.59% | US#2,133/3,111 Sec#159/269 |
| Trading | ||
| Volume | 18,464,077 shares | US#80/3,111 Sec#6/269 |
| Trading Value | $23M | US#1,791/3,111 Sec#129/269 |
| Per Share | ||
| EPS | $-0.13 | US—/3,111 Sec—/269 |
| BPS | $0.34 | US#2,704/3,111 Sec#227/269 |